tiprankstipranks
Nutriband Secures Chinese Patent for AVERSA™ Technology
Company Announcements

Nutriband Secures Chinese Patent for AVERSA™ Technology

Pick the best stocks and maximize your portfolio:

Nutriband ( (NTRB) ) has issued an announcement.

Nutriband Inc. has secured a full patent from the Chinese National Intellectual Property Administrant for its innovative “Abuse and Misuse Deterrent Transdermal System” related to their AVERSA™ technology. This development is pivotal for 4p Therapeutics’ system, which employs taste aversion to combat opioid patch abuse. The AVERSA™ technology aims to enhance the safety of transdermal drugs like fentanyl by preventing misuse while preserving access for patients in need. Nutriband’s technology spans a global patent portfolio, reflecting its potential impact on the pharmaceutical market.

Learn more about NTRB stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyNutriband reports record revenue for Q3, progress to NDA for AVERSA
TheFlyNutriband receives Hong Kong patent notice of publication for Aversa
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App